Ano Rectal Plasmablastic Lymphoma in HIV Positive Patient - A Case Report

Temesgen Assefa Ayele *

Department of Internal Medicine, Hematology Unit, Saint Peter Specialized Hospital, Ethiopia.

Ephrem Haile Gebreyesus

Department of Internal Medicine, Hematology Unit, Adissababa University, Ethiopia.

*Author to whom correspondence should be addressed.


Plasmablastic lymphoma (PBL) is an aggressive subtype of non-Hodgkin’s lymphoma (NHL), classified as a distinct entity by the WHO (2008) which frequently arises in the oral cavity of HIV infected patients [1]. It is usually associated with EBV infections, and MYC gene rearrangements [2]. PBL remains a diagnostic and a therapeutic challenge with high rate of relapse and death. There is no standard of care for this entity; current understanding & knowledge of PBL relies primarily on case reports and small case series.

We present a case of primary Ano rectal plasmablastic Lymphoma in a 24 years old male HIV positive patient from Ethiopia who presented with a 3 months history rectal bleeding & abdominal pain.

Keywords: Plasmablastic lymphoma, anorectal, HIV

How to Cite

Ayele , T. A., & Gebreyesus , E. H. (2023). Ano Rectal Plasmablastic Lymphoma in HIV Positive Patient - A Case Report. International Journal of Research and Reports in Hematology, 6(2), 228–232. Retrieved from


Download data is not yet available.


Jorge J.Castillo etal, The biology and treatment of plasmablastic lymphoma review article, Blood. 2015;125(15):2323–2330.

Jenique Bailly et al Plasma blastic Lymphoma an update, Int J Lab Hematol. Dec 2022;44(6):1121.

3.Knowels DM,Etiology and pathogenesis of AIDS related Lymphoma, Hematol Oncol Clin North Am. Jun 2003;17(3):785-820.

4.Castillo JJ et al., Prognostic factors in chemotherapy treated patients with HIV associated Plasmablastic Lymphoma, Oncologist . 2010;15(3):293-9.

Xibu Liu et al, Anal lymphoma: a tumor with insufficient attention. Discov Oncol. Dec 2023;14:88.

Elyamany G, Alzahrani AM, Aljuboury M et al. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia. Diagn Pathol 2015;10(78).

Harmon et al., Plasmablastic Lymphoma: A review of clinicopathologic features & differential diagnosis, Archives of Pathology & lab medicine. Arch Pathol Lab Med Oct 2016;140(10):1074-8.

Lynette Luria et al., Manifestation of Gastrointestinal plasmablastic Lymphoma: A case series with literature review. World J Gastroenterol. Sep 7 2014;20(33): 11894–11903.

Elyamany et al Plasmablastic lymphoma: A review of current knowledge & future directions, review article, Adv Hematol. 2015;2015: 315289.

Ando etal, Bortezomib and Lenalidomide based treatment of refractory plasmablastic lymphoma, Oncology research & treatment. Oncol Res Treat. 2020;43(3):112–116.